4//SEC Filing
Henderson Jeffrey William 4
Accession 0001415889-25-009440
CIK 0001159036other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:32 PM ET
Size
5.0 KB
Accession
0001415889-25-009440
Insider Transaction Report
Form 4
Henderson Jeffrey William
Director
Transactions
- Sale
Common Stock
2025-04-01$64.05/sh−503$32,217→ 33,108 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 17, 2024 in accordance with Rule 10b5-1.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001324015
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:32 PM ET
- Size
- 5.0 KB